ROSE
Otherrapid on-site evaluation by cytopathology
NCT Number: NCT00861835
Purpose: Previous studies suggested an increased diagnostic yield for bronchoscopic (FB) transbronchial needle aspirate (TBNA) specimens from mediastinal lymph nodes when using rapid on-site evaluation by cytopathology (ROSE) but were limited by lack of randomization. The investigators performed the first randomized-prospective trial comparing ROSE(R) to no on-site cytopathology assessment (NR).
Methods: All patients referred were eligible. 78 patients were randomized to R or NR groups. For R procedures, further specimens were deferred until results were available from the on-site cytopathologist. Diagnoses made by all procedures were recorded. The primary end-points were specimen adequacy and diagnostic yield.
Looking for future studies?
Notify MeHealthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
rapid on-site evaluation by cytopathology
MaineHealth
Other
A Randomized Prospective Trial of Rapid On-Site Evaluation of Transbronchial Needle Aspirate Specimens
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07639437
Bronchoscopy, General Anesthesia
Jakarta, Jakarta Special Capital Region, Indonesia
View Trial DetailsNCT06285994
Bronchoscopy, High-Frequency Jet Ventilation
Brussels, Belgium
View Trial DetailsNCT06908109
Bronchoscopy
View Trial DetailsNCT06441149
Behavior, Bronchoscopy
Beijing, Beijing Municipality, China
View Trial Details